Cancer cells with increased CD73 expression would have an advantage by accessing a broader range of extracellular NAD+ precursors for recycling and NAD+ biosynthesis, particularly if the tumor microenvironment provided localized NAD+ precursors such as NMN that could be used to elevate intracellular NAD+ levels60. This evidence concerns the gene NT5E and neoplasm.